Search

Tuan H. Nguyen

Examiner (ID: 4878)

Most Active Art Unit
2813
Art Unit(s)
2813, 3991, 3992, 1104
Total Applications
1968
Issued Applications
1723
Pending Applications
53
Abandoned Applications
192

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18449546 [patent_doc_number] => 20230190822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS [patent_app_type] => utility [patent_app_number] => 17/923431 [patent_app_country] => US [patent_app_date] => 2021-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22194 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17923431 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/923431
METHODS AND COMPOSITIONS FOR ENRICHMENT OF TARGET CELLS May 4, 2021 Pending
Array ( [id] => 17185220 [patent_doc_number] => 20210332105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/237498 [patent_app_country] => US [patent_app_date] => 2021-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12946 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237498 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/237498
Compositions and methods of treating cancer with chimeric antigen receptors Apr 21, 2021 Issued
Array ( [id] => 18364831 [patent_doc_number] => 20230146422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/996901 [patent_app_country] => US [patent_app_date] => 2021-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10485 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996901 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/996901
ANIMAL MODEL FOR STUDYING CANCER IMMUNOTHERAPY Apr 20, 2021 Pending
Array ( [id] => 17258480 [patent_doc_number] => 20210371465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-02 [patent_title] => METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT [patent_app_type] => utility [patent_app_number] => 17/213299 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8676 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213299 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/213299
METHOD OF USING A TLR9 ANTAGONIST AS AN ANTI-INFLAMMATORY AND ANTI-FIBROTIC AGENT Mar 25, 2021 Abandoned
Array ( [id] => 18676782 [patent_doc_number] => 20230314412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => Neuronal diencephalon stem cells, preparation and uses for treatment and prevention of hormonal disorders and other diseases [patent_app_type] => utility [patent_app_number] => 17/913403 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17913403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/913403
Neuronal diencephalon stem cells, preparation and uses for treatment and prevention of hormonal disorders and other diseases Mar 18, 2021 Pending
Array ( [id] => 16916237 [patent_doc_number] => 20210189329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => PRODUCTION OF EXTRACELLULAR VESICLES FROM STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/194972 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17422 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194972 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194972
Production of extracellular vesicles from stem cells Mar 7, 2021 Issued
Array ( [id] => 17853138 [patent_doc_number] => 20220283180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => TDP-43 IN DEGENERATIVE DISEASE [patent_app_type] => utility [patent_app_number] => 17/189967 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189967 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189967
TDP-43 IN DEGENERATIVE DISEASE Mar 1, 2021 Pending
Array ( [id] => 17297846 [patent_doc_number] => 20210393685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => ANTI-CD33 AND NKG2D LIGAND CHIMERAS FOR TREATMENT OF MYELOID MALIGNANCIES [patent_app_type] => utility [patent_app_number] => 17/182422 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25799 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182422 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182422
ANTI-CD33 AND NKG2D LIGAND CHIMERAS FOR TREATMENT OF MYELOID MALIGNANCIES Feb 22, 2021 Abandoned
Array ( [id] => 17022600 [patent_doc_number] => 20210246471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI [patent_app_type] => utility [patent_app_number] => 17/172818 [patent_app_country] => US [patent_app_date] => 2021-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6604 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172818 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/172818
MODIFICATION OF HEAVY CHAIN FIBROIN IN BOMBYX MORI Feb 9, 2021 Abandoned
Array ( [id] => 20077555 [patent_doc_number] => 12351605 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-08 [patent_title] => Optically controllable FGFR stimulation using wireless controlled cellular lighting system [patent_app_type] => utility [patent_app_number] => 17/152220 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 75 [patent_no_of_words] => 16945 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152220 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152220
Optically controllable FGFR stimulation using wireless controlled cellular lighting system Jan 18, 2021 Issued
Array ( [id] => 16805919 [patent_doc_number] => 20210128472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE [patent_app_type] => utility [patent_app_number] => 17/247661 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17247661 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/247661
EXTRACELLULAR VESICLES DERIVED FROM OSTEOBLAST LINEAGE CELLS FOR THERAPEUTIC AND DIAGNOSTIC USE Dec 17, 2020 Abandoned
Array ( [id] => 16750168 [patent_doc_number] => 20210102177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS [patent_app_type] => utility [patent_app_number] => 17/119484 [patent_app_country] => US [patent_app_date] => 2020-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12658 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17119484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/119484
DERIVATION OF HUMAN SKIN ORGANOIDS FROM PLURIPOTENT STEM CELLS Dec 10, 2020 Pending
Array ( [id] => 16728112 [patent_doc_number] => 20210095259 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => COMPOSITION AND METHOD FOR INDUCTION OF PLURIPOTENT STEM CELL [patent_app_type] => utility [patent_app_number] => 17/118555 [patent_app_country] => US [patent_app_date] => 2020-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3226 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17118555 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/118555
COMPOSITION AND METHOD FOR INDUCTION OF PLURIPOTENT STEM CELL Dec 9, 2020 Abandoned
Array ( [id] => 17657381 [patent_doc_number] => 20220177846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => GENOME-EDITED INDUCED PLURIPOTENT STEM CELLS, AND CELLS DERIVED THEREFROM, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/116332 [patent_app_country] => US [patent_app_date] => 2020-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28741 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116332 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/116332
Genome-edited induced pluripotent stem cells, and cells derived therefrom, and uses thereof Dec 8, 2020 Issued
Array ( [id] => 18108044 [patent_doc_number] => 20230000924 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY [patent_app_type] => utility [patent_app_number] => 17/781265 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12776 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17781265 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/781265
COMPOSITIONS AND METHODS FOR GENERATION OF SINOATRIAL NODE-LIKE CELLS AND THEIR USE IN DRUG DISCOVERY Dec 1, 2020 Pending
Array ( [id] => 18692906 [patent_doc_number] => 20230323263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => SPECIAL CULTURE APPARATUS FOR 3D BIOLOGICAL TISSUE, AND METHOD FOR PREPARING BLOCK-SHAPED CULTURED MEAT [patent_app_type] => utility [patent_app_number] => 18/022872 [patent_app_country] => US [patent_app_date] => 2020-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6344 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022872 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022872
SPECIAL CULTURE APPARATUS FOR 3D BIOLOGICAL TISSUE, AND METHOD FOR PREPARING BLOCK-SHAPED CULTURED MEAT Nov 26, 2020 Pending
Array ( [id] => 16901100 [patent_doc_number] => 20210180016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => PLATELETS LOADED WITH mRNA [patent_app_type] => utility [patent_app_number] => 17/104528 [patent_app_country] => US [patent_app_date] => 2020-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17104528 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/104528
PLATELETS LOADED WITH mRNA Nov 24, 2020 Abandoned
Array ( [id] => 16946673 [patent_doc_number] => 20210205364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => LONG LIVED ENGINEERED T CELLS FOR ADOPTIVE CELL THERAPY [patent_app_type] => utility [patent_app_number] => 17/099402 [patent_app_country] => US [patent_app_date] => 2020-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16126 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17099402 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/099402
LONG LIVED ENGINEERED T CELLS FOR ADOPTIVE CELL THERAPY Nov 15, 2020 Pending
Array ( [id] => 18167974 [patent_doc_number] => 20230034582 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => CELL POPULATION AND METHOD OF OBTAINING THE SAME [patent_app_type] => utility [patent_app_number] => 17/788285 [patent_app_country] => US [patent_app_date] => 2020-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788285 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788285
CELL POPULATION AND METHOD OF OBTAINING THE SAME Oct 7, 2020 Pending
Array ( [id] => 16570935 [patent_doc_number] => 20210009941 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => COMPOSITION THAT CONTAINS POLYLYSINE ANALOG AND PROMOTES CELL GROWTH [patent_app_type] => utility [patent_app_number] => 17/036476 [patent_app_country] => US [patent_app_date] => 2020-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6150 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17036476 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/036476
COMPOSITION THAT CONTAINS POLYLYSINE ANALOG AND PROMOTES CELL GROWTH Sep 28, 2020 Abandoned
Menu